Fast simultaneous detection of K-RAS mutations in colorectal cancer

被引:38
作者
Chang, Ya-Sian [1 ,2 ,3 ]
Yeh, Kun-Tu [4 ]
Chang, Tien-Jye [3 ]
Chai, Connie [1 ]
Lu, Hsiu-Chin [1 ]
Hsu, Nicholas C. [1 ]
Chang, Jan-Gowth [1 ,5 ,6 ]
机构
[1] Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung, Taiwan
[2] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan
[3] Natl Chung Hsing Univ, Dept Vet Med, Taichung, Taiwan
[4] Changhua Christian Hosp, Dept Pathol, Changhua, Taiwan
[5] Kaohsiung Med Univ, Inst Clin Med, Kaohsiung, Taiwan
[6] Kaohsiung Med Univ, Ctr Excellence Environm Med, Kaohsiung, Taiwan
来源
BMC CANCER | 2009年 / 9卷
关键词
POLYMERASE-CHAIN-REACTION; PEPTIDE NUCLEIC-ACID; CONFORMATION POLYMORPHISM ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISMS; PRIMER EXTENSION; POINT MUTATIONS; LUNG CANCERS; PCR; KRAS; ASSAY;
D O I
10.1186/1471-2407-9-179
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: RAS genes acquire the most common somatic gain-of-function mutations in human cancer, and almost all of these mutations are located at codons 12, 13, 61, and 146. Methods: We present a method for detecting these K-RAS hotspot mutations in 228 cases of colorectal cancer. The protocol is based on the multiplex amplification of exons 2, 3 and 4 in a single tube, followed by primer extension of the PCR products using various sizes of primers to detect base changes at codons 12, 13, 61 and 146. We compared the clinicopathological data of colorectal cancer patients with the K-RAS mutation status. Results: K-RAS mutation occurred in 36% (83/228) of our colorectal cancer cases. Univariate analysis revealed a significant association between K-RAS mutation at codon 12 of exon 2 and poor 5-year survival (p = 0.023) and lymph node involvement (p = 0.048). Also, K-RAS mutation at codon 13 of exon 2 correlates with the size of the tumor (p = 0.03). Multivariate analysis adjusted for tumor size, histologic grade, and lymph node metastasis also indicated K-RAS mutations at codon 12 and 13 of exon 2 correlate significantly with overall survival (p = 0.002 and 0.025). No association was observed between codon 61 and 146 and clinicopathological features. Conclusion: We demonstrated a simple and fast way to identify K-RAS mutation.
引用
收藏
页数:7
相关论文
共 41 条
[1]   Characterization of a novel oncogenic K-ras mutation in colon cancer [J].
Akagi, Kiwamu ;
Uchibori, Ryosuke ;
Yamaguchi, Kensei ;
Kurosawa, Keiko ;
Tanaka, Yoichiro ;
Kozu, Tomoko .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 352 (03) :728-732
[2]   Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer [J].
Amado, Rafael G. ;
Wolf, Michael ;
Peeters, Marc ;
Van Cutsem, Eric ;
Siena, Salvatore ;
Freeman, Daniel J. ;
Juan, Todd ;
Sikorski, Robert ;
Suggs, Sid ;
Radinsky, Robert ;
Patterson, Scott D. ;
Chang, David D. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (10) :1626-1634
[3]   Kirsten ras mutations in patients with colorectal cancer:: the 'RASCAL II' study [J].
Andreyev, HJN ;
Norman, AR ;
Cunningham, D ;
Oates, J ;
Dix, BR ;
Iacopetta, BJ ;
Young, J ;
Walsh, T ;
Ward, R ;
Hawkins, N ;
Beranek, M ;
Jandik, P ;
Benamouzig, R ;
Jullian, E ;
Laurent-Puig, P ;
Olschwang, S ;
Muller, O ;
Hoffmann, I ;
Rabes, HM ;
Zietz, C ;
Troungos, C ;
Valavanis, C ;
Yuen, ST ;
Ho, JWC ;
Croke, CT ;
O'Donoghue, DP ;
Giaretti, W ;
Rapallo, A ;
Russo, A ;
Bazan, V ;
Tanaka, M ;
Omura, K ;
Azuma, T ;
Ohkusa, T ;
Fujimori, T ;
Ono, Y ;
Pauly, M ;
Faber, C ;
Glaesener, R ;
de Goeij, AFPM ;
Arends, JW ;
Andersen, SN ;
Lövig, T ;
Breivik, J ;
Gaudernack, G ;
Clausen, OPF ;
De Angelis, P ;
Meling, GI ;
Rognum, TO ;
Smith, R .
BRITISH JOURNAL OF CANCER, 2001, 85 (05) :692-696
[4]   RAS GENES [J].
BARBACID, M .
ANNUAL REVIEW OF BIOCHEMISTRY, 1987, 56 :779-827
[5]   Mutation analyses of KRAS exon 1 comparing three different techniques:: temporal temperature gradient electrophoresis, constant denaturant capillary electrophoresis and allele specific polymerase chain reaction [J].
Bjorheim, J ;
Lystad, S ;
Lindblom, A ;
Kressner, U ;
Westring, S ;
Wahlberg, S ;
Lindmark, G ;
Gaudernack, G ;
Ekstrom, P ;
Roe, J ;
Thilly, WG ;
Borresen-Dale, AL .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1998, 403 (1-2) :103-112
[6]   PROTEINS REGULATING RAS AND ITS RELATIVES [J].
BOGUSKI, MS ;
MCCORMICK, F .
NATURE, 1993, 366 (6456) :643-654
[7]  
BOS JL, 1989, CANCER RES, V49, P4682
[8]   Mutant KRAS, chromosomal instability and prognosis in colorectal cancer [J].
Castagnola, P ;
Giaretti, W .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2005, 1756 (02) :115-125
[9]   Rapid detection of K-ras mutations in bile by peptide nucleic acid-mediated PCR clamping and melting curve analysis:: Comparison with restriction fragment length polymorphism analysis [J].
Chen, CY ;
Shiesh, SC ;
Wu, SJ .
CLINICAL CHEMISTRY, 2004, 50 (03) :481-489
[10]   GTPase activating proteins: critical regulators of intracellular signaling [J].
Donovan, S ;
Shannon, KM ;
Bollag, G .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2002, 1602 (01) :23-45